Pharmaceutical Executive
June 28, 2017
Features
37
6
Pharm Exec's 17th annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
June 26, 2017
Features
37
6
Outlining the new leadership and C-level roles of tomorrow needed to take on the disruption event on pharma's horizon.
June 12, 2017
Columns
37
6
An honoree at HBA’s recent Women of the Year awards luncheon, Bahija Jallal’s story is one of courage and resilience.
June 12, 2017
Features
37
6
With the patient voice growing louder in all aspects of the drug development and commercialization journey, Pharm Exec examines some of the current industry thinking on the evolving pharma-patient relationship.
June 12, 2017
Sponsored Content
37
6
A panel of biopharma executives discuss market access and the changing dynamics in reaching physicians and healthcare professionals.
June 09, 2017
From the Editor
37
6
There's no shortage of talent, expertise and passion in the biopharma industry. It's time for that talent to shine.
June 01, 2017
Columns
37
6
Several interventions and developments across the continent likely to keep discussions around drug affordability on high burn.
June 01, 2017
Columns
37
6
New legislation, administration priorities raise multiple challenges for new commissioner.
June 01, 2017
Special Sponsored Section
37
6
Although the local pharma and biotech sectors in Taiwan have yet to emulate the success story of its semiconductor industry, companies in the life sciences have reached a solid level of maturity, notably driven by the substantial investments injected by Taiwan’s successive governments over the past two decades.
June 01, 2017
Issue PDF
37
6
Click the title above to open the Pharmaceutical Executive June 2017 issue in an interactive PDF format.